Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 12:9:946277.
doi: 10.3389/fnut.2022.946277. eCollection 2022.

Serum Serine and the Risk of All-Cause Mortality: A Nested Case-Control Study From the China Stroke Primary Prevention Trial (CSPPT)

Qiangqiang He  1   2 , Nan Zhang  3 , Qiongyue Liang  4 , Zhuo Wang  5 , Ping Chen  6 , Yun Song  7   8 , Ziyi Zhou  1   2 , Yaping Wei  5 , Yong Duan  9   10 , Binyan Wang  2   11 , Peiwu Qin  12 , Xianhui Qin  11 , Xiping Xu  5   11
Affiliations

Serum Serine and the Risk of All-Cause Mortality: A Nested Case-Control Study From the China Stroke Primary Prevention Trial (CSPPT)

Qiangqiang He et al. Front Nutr. .

Abstract

Background: Serine plays a key role in numerous cellular processes, the levels and metabolism is therefore of critical importance. However, few data are available to illustrate the association of serine with long-term health effects, especially, the predictive value for long-term mortality.

Objective: This study was conducted to evaluate the relationship between serum serine levels and all-cause mortality in general hypertensive patients in a longitudinal cohort, and to examine the potential effect modifiers.

Methods: A nested case-control (NCC) study was conducted utilizing 20702 hypertensive participants from the China Stroke Primary Prevention Trial (CSPPT), a randomized, double-blind, actively controlled trial conducted from May 2008 to August 2013 in China. The current study included 291 cases of all-cause mortality and 291 controls matched on age (≤ 1 year), sex and treatment group. All-cause mortality was the main outcome in this analysis, which included death due to any reason.

Results: With the increase in serum serine levels, the risk of all-cause mortality first increased before flattening. After adjusting for related variables, the risk of mortality increased significantly with the increase of serum serine levels. Compared with group Q1, the mortality risk of group Q2, Q3 and Q4 were significantly increased [ORs, 95% CI: Q2: 2.32, (1.32-4.07); Q3: 2.59, (1.48-4.54); and Q4: 1.85, (1.07-3.22)]. In the exploratory analysis, we observed three effect modifiers, total homocysteine, 5-Methyltetrahydrofolate, and estimated glomerular filtration rate significantly modified the serum serine and all-cause mortality association.

Conclusion: Serum serine levels were significantly associated with an increased risk of all-cause mortality in hypertensive patients. Our results and findings, if confirmed further, suggest that serum serine should be considered as a marker for screening risk factors of mortality.

Clinical trial registration: [https://www.clinicaltrials.gov/ct2/show/study/NCT00794885.], identifier [CSPPT, NCT00794885].

Keywords: all-cause mortality; hypertension; longitudinal cohort; nutrition; serum serine.

PubMed Disclaimer

Conflict of interest statement

YS was employed by Shenzhen AUSA Pharmed Co Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study participants.
Figure 2
Figure 2
The relationship of serum serine with the risk of all-cause mortality1. 1Adjusted for age, sex, body mass index (BMI), treatment group, MTHFR C677T genotypes, smoking, alcohol drinking, systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), estimated glomerular filtration rate (eGFR) at baseline, folate, total homocysteine (tHcy), vitamin B12 as well as mean SBP and DBP during the treatment period.
See this image and copyright information in PMC

References

    1. Davis SR, Stacpoole PW, Williamson J, Kick LS, Quinlivan EP, Coats BS, et al. . Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am J Physiol-Endocrinol Metab. (2004) 286:E272–9. 10.1152/ajpendo.00351.2003 - DOI - PubMed
    1. Snell K, Natsumeda Y, Weber G. The modulation of serine metabolism in hepatoma 3924A during different phases of cellular proliferation in cluture. Biochemical Journal. (1987) 245:609–12. 10.1042/bj2450609 - DOI - PMC - PubMed
    1. Maddocks OD, Labuschagne CF, Adams PD, Vousden KH. Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol Cell. (2016) 61:210–21. 10.1016/j.molcel.2015.12.014 - DOI - PMC - PubMed
    1. Zeng JD, Wu WK, Wang HY Li XX. Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer. Pharmacol Res. (2019) 149:104352. 10.1016/j.phrs.2019.104352 - DOI - PubMed
    1. Parker SJ, Metallo CM. Chasing one-carbon units to understand the role of serine in epigenetics. Mol Cell. (2016) 61:185–6. 10.1016/j.molcel.2016.01.006 - DOI - PubMed

Associated data